Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
92 rows where has_known_aptamer = 0, surface_class = "A_assoc" and tier = "Tier 1" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total
tier 1
- Tier 1 · 92 ✖
surface_class 1
- A_assoc · 92 ✖
has_known_aptamer 1
- - · 92 ✖
has_activation_state_pdb_pair 1
- 0 92
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P12883 | MYH7 | Myosin-7 | Tier 1 | 0.871 | 1 | A_assoc | 43 | 74.25 | 1 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy | 0.9029865147265421 | |||
| P03951 | F11 | Coagulation factor XI | Tier 1 | 0.853 | 1 | A_assoc | 100 | 86.88 | 0 | 0 | 0 | 0 | 1 | factor XI deficiency | 0.841884208404384 | |||
| Q9BWP8 | COLEC11 | Collectin-11 | Tier 1 | 0.839 | 1 | A_assoc | 3 | 78.31 | 0 | 0 | 0 | 0 | 1 | 3MC syndrome 2 | 0.7977893521540559 | |||
| P20908 | COL5A1 | Collagen alpha-1(V) chain | Tier 1 | 0.839 | 1 | A_assoc | 1 | 51.25 | 0 | 0 | 0 | 0 | 1 | Ehlers-Danlos syndrome, classic type, 1 | 0.7979601586599098 | |||
| P02671 | FGA | Fibrinogen alpha chain | Tier 1 | 0.838 | 1 | A_assoc | 40 | 60.34 | 0 | 0 | 0 | 0 | 1 | familial dysfibrinogenemia | 0.7947496460990987 | |||
| P00488 | F13A1 | Coagulation factor XIII A chain | Tier 1 | 0.838 | 1 | A_assoc | 15 | 90.88 | 1 | 0 | 0 | 0 | 1 | Factor XIII subunit A deficiency | 0.7939842013132387 | |||
| P13645 | KRT10 | Keratin, type I cytoskeletal 10 | Tier 1 | 0.836 | 1 | A_assoc | 6 | 64.31 | 0 | 0 | 0 | 0 | 1 | epidermolytic hyperkeratosis 2A, autosomal dominant | 0.7860749239386174 | |||
| Q12904 | AIMP1 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 | Tier 1 | 0.834 | 1 | A_assoc | 6 | 81.12 | 0 | 0 | 0 | 0 | 1 | hypomyelinating leukodystrophy 3 | 0.7806847123659254 | |||
| O43707 | ACTN4 | Alpha-actinin-4 | Tier 1 | 0.833 | 1 | A_assoc | 5 | 84.12 | 0 | 0 | 0 | 0 | 1 | focal segmental glomerulosclerosis 1 | 0.7778533437264424 | |||
| P48200 | IREB2 | Iron-responsive element-binding protein 2 | Tier 1 | 0.799 | 1 | A_assoc | 1 | 86.75 | 1 | 0 | 0 | 0 | 1 | neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia | 0.664403876125082 | |||
| P02745 | C1QA | Complement C1q subcomponent subunit A | Tier 1 | 0.79 | 1 | A_assoc | 11 | 82.62 | 1 | 0 | 0 | 0 | 1 | C1Q deficiency 1 | 0.6319053256658114 | |||
| P02747 | C1QC | Complement C1q subcomponent subunit C | Tier 1 | 0.787 | 1 | A_assoc | 11 | 80.56 | 1 | 0 | 0 | 0 | 1 | C1Q deficiency | 0.6233532074390745 | |||
| P09486 | SPARC | SPARC | Tier 1 | 0.784 | 1 | A_assoc | 4 | 84.31 | 0 | 0 | 0 | 0 | 1 | osteogenesis imperfecta | 0.6138892200186172 | |||
| P04746 | AMY2A | Pancreatic alpha-amylase | Tier 1 | 0.78 | 1 | A_assoc | 51 | 96.75 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.5997984923419163 | |||
| P02749 | APOH | Beta-2-glycoprotein 1 | Tier 1 | 0.764 | 1 | A_assoc | 14 | 93.12 | 0 | 0 | 0 | 0 | 1 | atrial fibrillation | 0.5456247991985232 | |||
| A8K2U0 | A2ML1 | Alpha-2-macroglobulin-like protein 1 | Tier 1 | 0.764 | 1 | A_assoc | 5 | 80.5 | 1 | 0 | 0 | 0 | 1 | Otitis media | 0.5479914512784171 | |||
| P20061 | TCN1 | Transcobalamin-1 | Tier 1 | 0.763 | 1 | A_assoc | 2 | 89.12 | 0 | 0 | 0 | 0 | 1 | vitamin B deficiency | 0.5449702229454368 | |||
| Q14766 | LTBP1 | Latent-transforming growth factor beta-binding protein 1 | Tier 1 | 0.754 | 1 | A_assoc | 1 | 58.88 | 0 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.5142669818409414 | |||
| Q08043 | ACTN3 | Alpha-actinin-3 | Tier 1 | 0.752 | 1 | A_assoc | 3 | 84.19 | 1 | 0 | 0 | 0 | 1 | Abnormality of the skeletal system | 0.5080072819822437 | |||
| Q9H792 | PEAK1 | Inactive tyrosine-protein kinase PEAK1 | Tier 1 | 0.752 | 1 | A_assoc | 2 | 48.03 | 0 | 0 | 0 | 0 | 1 | type 2 diabetes mellitus | 0.5080681892268507 | |||
| Q04756 | HGFAC | Hepatocyte growth factor activator serine protease | Tier 1 | 0.747 | 1 | A_assoc | 7 | 75.31 | 0 | 0 | 0 | 0 | 1 | metabolic disease | 0.4900675680377984 | |||
| Q9UM22 | EPDR1 | Mammalian ependymin-related protein 1 | Tier 1 | 0.746 | 1 | A_assoc | 3 | 85.88 | 0 | 0 | 0 | 0 | 1 | Dupuytren Contracture | 0.48568453021554975 | |||
| Q07157 | TJP1 | Tight junction protein 1 | Tier 1 | 0.741 | 1 | A_assoc | 19 | 54.62 | 0 | 0 | 0 | 0 | 1 | dengue disease | 0.47083190223446686 | |||
| P05161 | ISG15 | Ubiquitin-like protein ISG15 | Tier 1 | 0.74 | 1 | A_assoc | 22 | 85.88 | 1 | 0 | 0 | 0 | 1 | COVID-19 | 0.4668295741563516 | |||
| P0DUB6 | AMY1A | Alpha-amylase 1A | Tier 1 | 0.738 | 1 | A_assoc | 13 | 96.69 | 0 | 0 | 0 | 0 | 1 | dentures | 0.4597705945086364 | |||
| Q9NR12 | PDLIM7 | PDZ and LIM domain protein 7 | Tier 1 | 0.738 | 1 | A_assoc | 2 | 70.25 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4602637679250804 | |||
| Q9BVC4 | MLST8 | Target of rapamycin complex subunit LST8 | Tier 1 | 0.733 | 1 | A_assoc | 45 | 91.62 | 1 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.4440338170862142 | |||
| P19827 | ITIH1 | Inter-alpha-trypsin inhibitor heavy chain H1 | Tier 1 | 0.731 | 1 | A_assoc | 2 | 87.44 | 0 | 0 | 0 | 0 | 1 | osteoarthritis, hip | 0.4360348893142765 | |||
| Q92187 | ST8SIA4 | CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase | Tier 1 | 0.731 | 1 | A_assoc | 3 | 86.44 | 0 | 0 | 0 | 0 | 1 | systemic lupus erythematosus | 0.43832763677821385 | |||
| Q14192 | FHL2 | Four and a half LIM domains protein 2 | Tier 1 | 0.711 | 1 | A_assoc | 4 | 92.06 | 0 | 0 | 0 | 0 | 1 | familial isolated dilated cardiomyopathy | 0.3714277539581253 | |||
| P26447 | S100A4 | Protein S100-A4 | Tier 1 | 0.709 | 1 | A_assoc | 17 | 86.44 | 0 | 0 | 0 | 0 | 1 | Alzheimer disease | 0.36416197951415524 | |||
| O95399 | UTS2 | Urotensin-2 | Tier 1 | 0.706 | 1 | A_assoc | 2 | 58.44 | 0 | 0 | 0 | 0 | 1 | hair color | 0.35316475479030335 | |||
| O00602 | FCN1 | Ficolin-1 | Tier 1 | 0.705 | 1 | A_assoc | 7 | 84.94 | 0 | 0 | 0 | 0 | 1 | neurodegenerative disease | 0.351581018821974 | |||
| P41222 | PTGDS | Prostaglandin-H2 D-isomerase | Tier 1 | 0.703 | 1 | A_assoc | 17 | 87.81 | 0 | 0 | 0 | 0 | 1 | keratoconus | 0.3422478065390684 | |||
| Q9NZK5 | ADA2 | Adenosine deaminase 2 | Tier 1 | 0.699 | 1 | A_assoc | 2 | 95.81 | 0 | 0 | 0 | 0 | 0 | deficiency of adenosine deaminase 2 | 0.8291292532404531 | |||
| Q99972 | MYOC | Myocilin | Tier 1 | 0.699 | 1 | A_assoc | 24 | 78.94 | 0 | 0 | 0 | 0 | 0 | glaucoma 1, open angle, A | 0.8294483747483756 | |||
| P48059 | LIMS1 | LIM and senescent cell antigen-like-containing domain protein 1 | Tier 1 | 0.697 | 1 | A_assoc | 14 | 88.06 | 0 | 0 | 0 | 0 | 1 | Abruptio Placentae | 0.3236383460637068 | |||
| O75629 | CREG1 | Protein CREG1 | Tier 1 | 0.697 | 1 | A_assoc | 1 | 87.38 | 0 | 0 | 0 | 0 | 1 | acquired neutropenia | 0.3238393577317927 | |||
| Q9UK55 | SERPINA10 | Protein Z-dependent protease inhibitor | Tier 1 | 0.697 | 1 | A_assoc | 4 | 86.75 | 0 | 0 | 0 | 0 | 1 | macular degeneration | 0.3247169581531489 | |||
| O60711 | LPXN | Leupaxin | Tier 1 | 0.697 | 1 | A_assoc | 4 | 76.38 | 0 | 0 | 0 | 0 | 1 | myopathy | 0.32321299435969897 | |||
| Q9UBH0 | IL36RN | Interleukin-36 receptor antagonist protein | Tier 1 | 0.695 | 1 | A_assoc | 3 | 92.44 | 0 | 0 | 0 | 0 | 0 | psoriasis 14, pustular | 0.8155144873787125 | |||
| P19652 | ORM2 | Alpha-1-acid glycoprotein 2 | Tier 1 | 0.695 | 1 | A_assoc | 5 | 91.19 | 0 | 0 | 0 | 0 | 1 | complication | 0.3155973286233708 | |||
| Q96MK3 | FAM20A | Pseudokinase FAM20A | Tier 1 | 0.693 | 1 | A_assoc | 4 | 85.25 | 0 | 0 | 0 | 0 | 0 | amelogenesis imperfecta type 1G | 0.8106031517056754 | |||
| P55000 | SLURP1 | Secreted Ly-6/uPAR-related protein 1 | Tier 1 | 0.692 | 1 | A_assoc | 2 | 84.19 | 0 | 0 | 0 | 0 | 0 | mal de Meleda | 0.8064330379723671 | |||
| P29460 | IL12B | Interleukin-12 subunit beta | Tier 1 | 0.687 | 1 | A_assoc | 20 | 91.12 | 1 | 0 | 0 | 0 | 0 | psoriasis | 0.7914863943708039 | |||
| P20849 | COL9A1 | Collagen alpha-1(IX) chain | Tier 1 | 0.678 | 1 | A_assoc | 5 | 61.5 | 0 | 0 | 0 | 0 | 0 | Stickler syndrome | 0.7594904923903256 | |||
| Q2MKA7 | RSPO1 | R-spondin-1 | Tier 1 | 0.669 | 1 | A_assoc | 12 | 74.69 | 1 | 0 | 0 | 0 | 0 | palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome | 0.7285342885472184 | |||
| P12272 | PTHLH | Parathyroid hormone-related protein | Tier 1 | 0.666 | 1 | A_assoc | 11 | 62.88 | 1 | 0 | 0 | 0 | 0 | brachydactyly type E | 0.7203484375635054 | |||
| Q99574 | SERPINI1 | Neuroserpin | Tier 1 | 0.665 | 1 | A_assoc | 3 | 88.12 | 0 | 0 | 0 | 0 | 0 | familial encephalopathy with neuroserpin inclusion bodies | 0.7162803151916303 | |||
| Q8N300 | SVBP | Small vasohibin-binding protein | Tier 1 | 0.649 | 1 | A_assoc | 24 | 85.06 | 1 | 0 | 0 | 0 | 0 | neurodevelopmental disorder with ataxia, hypotonia, and microcephaly | 0.6640118055835142 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;